Benign intracranial hypertension induced by growth hormone treatment.
作者信息
Price D A, Clayton P E, Lloyd I C
出版信息
Lancet. 1995 Feb 18;345(8947):458-9. doi: 10.1016/s0140-6736(95)90444-1.
PMID:7853981
Abstract
摘要
相似文献
1
Benign intracranial hypertension induced by growth hormone treatment.
Lancet. 1995 Feb 18;345(8947):458-9. doi: 10.1016/s0140-6736(95)90444-1.
2
[Benign intracranial hypertension as a secondary effect of treatment with a biosynthetic growth hormone].
An Esp Pediatr. 1996 May;44(5):507-8.
3
Complications of growth hormone therapy in children.
Curr Opin Pediatr. 1995 Aug;7(4):466-71. doi: 10.1097/00008480-199508000-00020.
4
Delayed onset of pseudotumor cerebri syndrome 7 years after starting human recombinant growth hormone treatment.
Eur J Ophthalmol. 2006 Jan-Feb;16(1):178-80. doi: 10.1177/112067210601600131.
5
Growth hormone treatment and pseudotumor cerebri: coincidence or close relationship?
J Pediatr Endocrinol Metab. 2002 May;15 Suppl 2:723-30. doi: 10.1515/jpem.2002.15.s2.723.
6
Growth hormone, insulin-like growth factor I, and benign intracranial hypertension.
N Engl J Med. 1993 Aug 26;329(9):665-6. doi: 10.1056/NEJM199308263290917.
7
Acute glaucoma and intracranial hypertension in a child on long-term peritoneal dialysis treated with growth hormone.
Pediatr Nephrol. 1995 Dec;9(6):742-5. doi: 10.1007/BF00868727.
8
Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone.
J Pediatr. 1995 Jun;126(6):996-9. doi: 10.1016/s0022-3476(95)70232-6.
9
Lithium-induced headache.
Headache. 1989 Apr;29(4):246-7. doi: 10.1111/j.1526-4610.1989.hed22904246.x.
10
Benign intracranial hypertension. Sequel to tetracycline therapy in a child.
JAMA. 1971 May 31;216(9):1479-80. doi: 10.1001/jama.216.9.1479.
引用本文的文献
1
Pseudotumor Cerebri in a Child with Idiopathic Growth Hormone Insufficiency Two Months after Initiation of Recombinant Human Growth Hormone Treatment.
Case Rep Ophthalmol Med. 2016;2016:4756894. doi: 10.1155/2016/4756894. Epub 2016 Feb 4.
2
Cerebrospinal fluid dynamics in the human cranial subarachnoid space: an overlooked mediator of cerebral disease. II. In vitro arachnoid outflow model.
J R Soc Interface. 2010 Aug 6;7(49):1205-18. doi: 10.1098/rsif.2010.0032. Epub 2010 Mar 24.
Zotero 插件